- Report
- September 2024
- 80 Pages
Saudi Arabia
From €3420EUR$3,500USD£2,855GBP
- Report
- October 2023
- 183 Pages
Global
From €4397EUR$4,500USD£3,671GBP
- Report
- August 2024
- 82 Pages
Japan
From €3420EUR$3,500USD£2,855GBP
- Report
- October 2023
- 140 Pages
Global
From €2930EUR$2,999USD£2,446GBP
- Report
- April 2023
- 147 Pages
Global
From €5861EUR$5,999USD£4,893GBP
- Report
- May 2022
- 163 Pages
Global
From €3517EUR$3,600USD£2,936GBP
- Report
- May 2022
- 80 Pages
Europe
From €1466EUR$1,500USD£1,224GBP
- Report
- October 2024
- 101 Pages
Turkey
From €2675EUR$2,933USD£2,311GBP
- Report
- October 2024
- 23 Pages
Turkey
From €995EUR$1,091USD£860GBP
- Report
- October 2024
- 25 Pages
Slovakia
From €995EUR$1,091USD£860GBP
- Report
- October 2024
- 25 Pages
Peru
From €995EUR$1,091USD£860GBP
- Report
- September 2024
- 116 Pages
Mexico
From €2675EUR$2,933USD£2,311GBP
- Report
- September 2024
- 114 Pages
Belgium
From €2675EUR$2,933USD£2,311GBP
- Report
- September 2024
- 28 Pages
Belgium
From €995EUR$1,091USD£860GBP
- Report
- September 2024
- 28 Pages
Mexico
From €995EUR$1,091USD£860GBP
- Report
- September 2024
- 26 Pages
France
From €995EUR$1,091USD£860GBP
- Report
- June 2023
- 132 Pages
Global
From €928EUR$950USD£775GBP
- Report
- April 2022
- 133 Pages
Global
From €3377EUR$3,456USD£2,819GBP
The Over the Counter (OTC) Analgesics market is a segment of the OTC Drugs industry that focuses on providing relief from pain and discomfort. These products are available without a prescription and are typically used to treat mild to moderate pain. Common OTC analgesics include acetaminophen, ibuprofen, and aspirin. These products are available in a variety of forms, such as tablets, capsules, liquids, and topical creams.
The OTC Analgesics market is highly competitive, with a wide range of products available from both large and small companies. Major players in the market include Bayer, Pfizer, Johnson & Johnson, GlaxoSmithKline, and Novartis. Other companies in the market include Perrigo, Prestige Brands, and Sun Pharmaceuticals. Show Less Read more